Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) rose 47.4% during trading on Saturday . The company traded as high as C$0.14 and last traded at C$0.14. Approximately 1,312,210 shares traded hands during mid-day trading, an increase of 427% from the average daily volume of 249,010 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Stock Performance
The company has a market cap of C$19.53 million, a P/E ratio of -14.00 and a beta of 0.32. The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21. The business has a fifty day simple moving average of C$0.08 and a two-hundred day simple moving average of C$0.06.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- Airline Stocks – Top Airline Stocks to Buy Now
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- Canada Bond Market Holiday: How to Invest and Trade
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- Differences Between Momentum Investing and Long Term Investing
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
